Home
Duchenne
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Our Tools
Exon Check Tool
Clinical Trials
Active Studies
Trial Statistics
Trials Map
Pipeline
Search
About Us
Contact
APPs
Privacy Policy
type here...
Search
Instagram
Facebook
Home
Duchenne
Duchenne MD
What is Duchenne?
Genetic Causes
Creatine Kinase (CK)
Genetic Testing
Prenatal Testing
Becker MD
DMD vs BMD
NSAA Assessment
Genetic
Genetic Counseling
Dystrophin Gene
Genetic Variants
Exon Deletion
Duchenne Carriers
Nucleotides in DMD
Isoforms in DMD
What is Exon Skipping
Care Guidelines
Newly Diagnosed
Neuromuscular Team
Respiratory Devices
BiPAP Machine
Ankle Foot Orthosis
Rhabdomyolysis
Power Wheelchair
Traveling with DMD
Health Guidelines
Psychological Support in DMD
Nutrition in DMD
Nutraceuticals
Respiratory Health
Dental Health
Surgery & Anesthesia
Swallowing Difficulty
Steroids (Cortisone)
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Our Tools
Exon Check Tool
Clinical Trials
Active Studies
Trial Statistics
Trials Map
Pipeline
WhatsAPP
Facebook
Instagram
X
Youtube
Latest Posts
Press Releases
STM-01 Enters Phase 2 Clinical Trial for Duchenne Muscular Dystrophy
Care Guidelines
Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD
Research
Keros Therapeutics Doses First Patient in Phase 2 Rinvatercept Trial
Articles by:
Theodore Martin
Press Releases
STM-01 Enters Phase 2 Clinical Trial for Duchenne Muscular Dystrophy
Editorials
The Systemic Failure of DMD Associations: Why Duchenne Patients Are Still Waiting
Editorials
World Duchenne Awareness Day 2026 (#WDAD2026)
Research
tRNA Research for Nonsense Mutations Offers New Hope for Genetic Disorders
Editorials
7 Breakthrough DMD Research Programs That Could Transform Duchenne Treatment in 2026
Latest Posts
Press Releases
STM-01 Enters Phase 2 Clinical Trial for Duchenne Muscular Dystrophy
Care Guidelines
Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD
Research
Keros Therapeutics Doses First Patient in Phase 2 Rinvatercept Trial
Editorials
The Systemic Failure of DMD Associations: Why Duchenne Patients Are Still Waiting
Don't Miss
Press Releases
SAT-3247 Six-Month TRAILHEAD Results Show Reduced Muscle Fat and Lower CK in Adults with Duchenne muscular dystrophy
DMD
How Can My Child Participate in Duchenne Clinical Trials?
Press Releases
Satellos Receives FDA Fast Track Designation for SAT-3247 in Duchenne Muscular Dystrophy
Press Releases
Elixirgen and Nippon Shinyaku Partner on Full-Length Dystrophin Therapy for Duchenne
Press Releases
REGENXBIO Completes RGX-202 Confirmatory Study for Duchenne Muscular Dystrophy
EN
AR
ZH
FR
DE
HI
RU
PT
ES
TR